BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26467642)

  • 21. CatroxMP-II: a heme-modulated fibrinogenolytic metalloproteinase isolated from Crotalus atrox venom.
    Suntravat M; Langlais PR; Sánchez EE; Nielsen VG
    Biometals; 2018 Aug; 31(4):585-593. PubMed ID: 29761254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De Novo Assessment and Review of Pan-American Pit Viper Anticoagulant and Procoagulant Venom Activities via Kinetomic Analyses.
    Nielsen VG; Frank N; Afshar S
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30736322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Jul; 42(1):33-7. PubMed ID: 26407681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ancrod revisited: viscoelastic analyses of the effects of Calloselasma rhodostoma venom on plasma coagulation and fibrinolysis.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Aug; 42(2):288-93. PubMed ID: 26905070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII-deficient plasmas.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):41-5. PubMed ID: 19923981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon Monoxide-Releasing Molecule Enhances Coagulation and Decreases Fibrinolysis in Normal Canine Plasma.
    Donaghy D; Yoo S; Johnson T; Nielsen V; Olver C
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):257-262. PubMed ID: 29577635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
    Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
    Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
    Nielsen VG; Arkebauer MR; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
    Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
    J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme.
    Nielsen VG; Frank N; Matika RW
    Biometals; 2018 Feb; 31(1):51-59. PubMed ID: 29170850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ruthenium, Not Carbon Monoxide, Inhibits the Procoagulant Activity of
    Nielsen VG
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity.
    Nielsen VG; Malayaman SN; Khan ES; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):349-53. PubMed ID: 20449889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2.
    Machovec KA; Ushakumari DS; Welsby IJ; Nielsen VG
    Thromb Res; 2012 Jun; 129(6):793-6. PubMed ID: 21872302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulant activity of krait, coral snake, and cobra neurotoxic venoms with diverse proteomes are inhibited by carbon monoxide.
    Nielsen VG; Frank N; Turchioe BJ
    Blood Coagul Fibrinolysis; 2019 Dec; 30(8):379-384. PubMed ID: 31415248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron and carbon monoxide enhance coagulation and attenuate fibrinolysis by different mechanisms.
    Nielsen VG; Pretorius E
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):695-702. PubMed ID: 24732176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of L-amino Acid Oxidase Derived from
    Nielsen VG
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31574907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.